Pivotal study of PRT-201 for hemodialysis vascular access in patients with chronic kidney disease July 22, 2014
Regulus Therapeutics' anti-miR-21 oligonucleotide awarded FDA orphan drug status for Alport syndrome July 22, 2014
Humanetics awarded NCI grant to test BIO-300 for radiation-induced erectile dysfunction July 10, 2014
Quark completes study of QPI-1002 to prevent delayed graft function in kidney transplantation July 4, 2014
RSS